Add BrightSurf on Google Email

Search results for “Oncology”

1,000+ results for "Oncology"

ASTRO updates guideline on radiation therapy for high-grade diffuse glioma, the most common primary brain tumor in adults

The American Society for Radiation Oncology (ASTRO) has updated its guideline on radiation therapy for high-grade diffuse gliomas, the most common primary brain tumor in adults. The new guideline provides evidence-based recommendations for multidisciplinary treatment and addresses optimal radiation dosing, fractionation, and techniques.

SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·DateJun 26, 2025

WIN International Molecular Tumor Board recommends tailored treatment for advanced colorectal cancer

A new precision oncology paper presents a case of a 62-year-old man with metastatic colorectal cancer who underwent multiple lines of therapy. The WIN International Molecular Tumor Board proposed personalized treatment plans based on the tumor's unique genetic mutations, highlighting the growing role of precision oncology in guiding th...

SourceImpact Journals LLC·JournalOncotarget·TypeCase study·DateJun 24, 2025

Alliance presents results from phase III ATOMIC trial combining atezolizumab with chemotherapy for patients with stage III dMMR colon cancer at ASCO 2025

The ATOMIC trial demonstrates a statistically significant improvement in disease-free survival with the addition of atezolizumab to standard adjuvant FOLFOX chemotherapy. Patients treated with atezolizumab had a 50% lower risk of disease recurrence or death compared to those receiving chemotherapy alone.

Largest genomic study of veterans with metastatic prostate cancer reveals critical insights for precision medicine

The study found key differences in tumor biology between non-Hispanic Black and non-Hispanic white veterans, but similar survival outcomes when both groups had equal access to care. The research highlights the importance of broadening access to genomic tools and prioritizing equity in cancer treatment.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalJAMA Network Open·TypeObservational study·DateMay 16, 2025

Building trust in artificial intelligence for healthcare: Lessons from clinical oncology

A new review advocates for building confidence in AI applications by implementing robust data governance frameworks, enhancing transparency, and involving stakeholders. The authors emphasize the importance of addressing ethical implications and ensuring equitable access to AI-driven innovations in clinical oncology.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalAI in Precision Oncology·TypeCommentary/editorial·DateApr 30, 2025

USC Norris Comprehensive Cancer Center opens state-of-the-art Newport Beach Radiation Oncology and Imaging Center

The new Keck Medicine of USC – Newport Beach Radiation Oncology and Imaging Center offers biology-guided radiation therapy, using up-to-the-minute signals to track and treat cancer cells in real time. The center is equipped with state-of-the-art technology and will be the first in Orange County to provide this treatment option.

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

The NRG Oncology GOG-0263 phase III clinical trial found that adding cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy did not improve outcomes and led to increased toxicity. Radiotherapy alone remains the standard of care for early-stage, intermediate-risk cervical cancer.

F. W. Bert and Mae Dean Wheeler Foundation establishes Nurse Leadership Academy at MD Anderson with $9 million gift

The F. W. Bert and Mae Dean Wheeler Nurse Leadership Academy at MD Anderson aims to cultivate oncology nurse leaders through coaching, mentoring, and continuous learning opportunities. The academy will focus on empowering nurses to reach their personal and professional goals, driving industry change and improving healthcare systems.

ASTRO issues its first clinical guideline on radiation therapy for anal cancer

The American Society for Radiation Oncology (ASTRO) has published its first clinical guideline on radiation therapy for anal cancer, providing guidance on treatment options and techniques. The guideline recommends a combination of radiation therapy and drug therapy as the standard of care, with intensity-modulated radiation therapy (IM...

SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·DateFeb 27, 2025

Moffitt Research advocates for routine brain MRI screening in asymptomatic late stage breast cancer patients

A new study published in Neuro-Oncology found that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously thought. The study suggests that doctors may need to rethink current screening guidelines for detecting brain metastasis in patients without symptoms.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalNeuro-Oncology·TypeData/statistical analysis·DateJan 28, 2025

NRG Oncology study suggests the addition of SBRT to systemic therapy improves outcomes for select patients with locally advanced hepatocellular carcinoma

A Phase III clinical trial found that stereotactic body radiotherapy (SBRT) added to sorafenib improved progression-free survival and overall survival in patients with locally advanced hepatocellular carcinoma, particularly those with macrovascular invasion. The study also showed improvements in quality of life for these patients.

SourceNRG Oncology·JournalJAMA Oncology·DateDec 19, 2024

UNC researchers awarded up to $10M to leverage data science to accelerate cancer diagnosis and optimize delivery of precision oncology

A team of UNC-Chapel Hill researchers will develop an oncology health learning system using AI-ready data to generate real-time identification of new cancer cases and support personalized treatments. The project aims to improve cancer diagnosis, care equity, and quality by creating accessible tools for health providers.

UCLA at ASTRO: Predicting response to chemoradiotherapy in rectal cancer, 2-year outcomes of MRI-guided radiotherapy for prostate cancer, impact of symptom self-reporting during chemoradiation and more

UCLA investigators presented data on chemoradiotherapy in rectal cancer, MRI-guided radiotherapy for prostate cancer, and symptom self-reporting during treatment. Researchers developed a predictive model to identify patients most likely to respond to chemoradiotherapy in rectal cancer.

Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer

The Cancer Cooperative Group System is being re-engineered to bring new money to correlative science research through public-private partnerships, aiming to remove barriers for researchers to access biological samples. This will facilitate the integration of innovative science into cancer clinical trials.

SourceECOG-ACRIN Cancer Research Group·JournalJournal of Clinical Oncology·TypeCommentary/editorial·DateSep 18, 2024

Quality-of-life outcomes reported from NRG Oncology trial studying whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery

A new study from NRG Oncology found that whole-breast irradiation (WBI) was not statistically equivalent to accelerated partial-breast irradiation (APBI) in local tumor control. The QOL sub-study also showed that APBI may be preferred by some patients due to reduced fatigue and extended treatment time.

SourceNRG Oncology·JournalJNCI Journal of the National Cancer Institute·TypeRandomized controlled/clinical trial·DateSep 16, 2024

Long-course radiotherapy is better than short-course for organ preservation in rectal cancer

A new study published in Annals of Oncology found that long-course radiotherapy is safer and more effective than short-course radiotherapy for preserving organs in rectal cancer patients. The treatment was shown to prevent regrowth of the primary tumour, but had similar overall survival rates.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·TypeObservational study·DateSep 11, 2024